Disc Medicine, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 598.14%3,296.80%19,056.29%
EBIT Margin 498.68%3,197.50%22,678.32%
EBITDA Margin 498.68%3,197.50%22,678.32%
Operating Margin 498.68%3,197.50%22,678.32%
Net Margin 598.14%3,296.80%19,118.36%
FCF Margin 479.49%1,279.05%16,508.92%
Leverage & Solvency
Interest Coverage Ratio -4.99-31.97-226.78
Times Interest Earned -4.99-31.97-226.78
Valuation
Enterprise Value 170.89M125.46M86.18M1,394.35M1,886.64M
Market Capitalization 170.89M125.46M86.18M1,394.35M1,886.64M
Return Ratios
Return on Sales 5.98%32.97%191.18%